Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
1421373-65-0
Purity
95%
Osimertinib is an oral, third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. Osimertinib is used in the treatment of certain types of non-small cell lung carcinoma.
Properties
Name
Osimertinib
Smiles
COC=1C=C(N(C)CCN(C)C)C(NC(=O)C=C)=CC1NC=2N=CC=C(N2)C3=CN(C)C=4C=CC=CC34
Targets
Please log in to see this information
SDS
AZD‐9291 | azd9291 | mereletinib | osimertinib | tagrisso
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$POA
Quantity
1
Total amount
$ 19
AZD‐9291 | azd9291 | mereletinib | osimertinib | tagrisso
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.